Munchus MS, Levitt D. Sera used for complement-mediated cytolysis can alter B cell function in vitro.
J Immunol Methods 1984;
66:383-8. [PMID:
6361160 DOI:
10.1016/0022-1759(84)90352-1]
[Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
Abstract
Nonspecific effects of reagents used to selectively isolate lymphocyte subpopulations are most often analyzed according to their influence on cell viability and proliferation. While characterizing monoclonal anti-human B cell antibodies, we detected consistent changes in B cell function between individual donors, no matter which antibody was employed to deplete B cell subpopulations. The source of these alterations was traced to the commercial complement-containing sera used for cytolysis. Different lots of serum from 3 separate commercial vendors and 2 animal species (rabbit and guinea pig) routinely altered B lymphocyte differentiation after stimulation with either pokeweed mitogen or Staphylococcus aureus (Cowan I), while cell viability, lymphocyte subpopulation distribution, and proliferative responses were unaffected.
Collapse